An enhanced self-renewal of hematopoietic stem/progenitor cells, combined with a decreased apoptosis rate and upregulation of cytokine receptor genes in p300-deficient cells drove leukemogenesis, identifying p300 as tumor suppressor [110]. This evidence concerns the gene EP300 and neoplasm.